| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |